2. Oligonucleotides
  3. Nucleosides and their Analogs
  4. I

I

Inosine

I (50):

Cat. No. Product Name CAS No. Purity Chemical Structure
  • HY-B0249
    Didanosine 69655-05-6 99.45%
    Didanosine (2',3'-Dideoxyinosine; ddI) is a a potent and orally active dideoxynucleoside analogue, and also is a potent nucleoside reverse transcriptase inhibitor. Didanosine shows antiretroviral activity for HIV.
    Didanosine
  • HY-W008638
    2'-Deoxyinosine 890-38-0 99.83%
    2’-deoxyadenosine inhibits the growth of human colon-carcinoma cell lines and is found to be associated with purine nucleoside phosphorylase (PNP) deficiency.
    2'-Deoxyinosine
  • HY-128671
    6-​Thioinosine 574-25-4 99.31%
    6-​Thioinosine (6TI) is a purine antimetabolite, acts as an anti-adipogenesis agent, downregulates mRNA levels of PPAR γ and C/EBPα, as well as PPAR γ target protein such as LPL, CD36, aP2, and LXRα.
    6-​Thioinosine
  • HY-W013289
    2'-O-Methylinosine 3881-21-8 99.27%
    9-((2R,3R,4R,5R)-4-Hydroxy-5-(hydroxymethyl)-3-methoxytetrahydrofuran-2-yl)-9H-purin-6-ol (2'-O-methylinosine) is a purine nucleoside analogue. Purine nucleoside analogs have broad antitumor activity targeting indolent lymphoid malignancies. Anticancer mechanisms in this process rely on inhibition of DNA synthesis, induction of apoptosis, etc.
    2'-O-Methylinosine
  • HY-151414
    3'-Deoxyinosine 13146-72-0 99.84%
    3'-Deoxyinosine is a purine nucleoside analog. Purine nucleoside analogs have broad antitumor activity targeting indolent lymphoid malignancies. Anticancer mechanisms in this process rely on inhibition of DNA synthesis, induction of apoptosis, etc.
    3'-Deoxyinosine
  • HY-W010744
    DMT-dI 93778-57-5 99.40%
    DMT-dI (5'-O-DMT-dI) is a deoxyribonucleoside containing a hypoxanthine base. DMT-dI can be used to prepare convertible nucleoside derivatives to prepare modified oligonucleotides complementary to target genes for gene editing. DMT-dI can be used to study various conditions, disorders or diseases modified by adenosine.
    DMT-dI
  • HY-138608
    5'-O-DMT-rI 119898-59-8 99.17%
    5'-O-DMT-Ri can be used in the synthesis of oligoribonucleotides.
    5'-O-DMT-rI
  • HY-148166
    L-Inosine 21138-24-9 99.91%
    L-Inosine is the L-configuration of Inosine (HY-N0092). Inosine is an endogenous purine nucleoside produced by catabolism of adenosine. Inosine has anti-inflammatory, antinociceptive, immunomodulatory and neuroprotective effects.
    L-Inosine
  • HY-W013156
    2′,3′,5′-Triacetylinosine 3181-38-2
    2′,3′,5′-Triacetylinosine (2′,3′,5′-Tri-O-acetylinosine) has been shown to inhibit the growth of cancer cells, and is also an efficient method for bond cleavage and radiation protection. 2',3',5'-Tri-O-acetylinosine has been shown to bind to pyridinium ions, and it has been used in the synthesis of tetrapeptides with hydroxyl groups or alkylation.
    2′,3′,5′-Triacetylinosine
  • HY-152501
    8-Chloro-2’-O-methyl inosine
    8-Chloro-2’-O-methyl inosine is a purine nucleoside analog. Purine nucleoside analogs have broad antitumor activity targeting indolent lymphoid malignancies. Anticancer mechanisms in this process rely on inhibition of DNA synthesis, induction of apoptosis, etc.
    8-Chloro-2’-O-methyl inosine
  • HY-152577
    3’-O-(2-Methoxyethyl) inosine
    3’-O-(2-Methoxyethyl) inosine is a purine nucleoside analog. Purine nucleoside analogs have broad antitumor activity targeting indolent lymphoid malignancies. Anticancer mechanisms in this process rely on inhibition of DNA synthesis, induction of apoptosis, etc.
    3’-O-(2-Methoxyethyl) inosine
  • HY-152447
    3’-beta-C-Ethynyl inosine
    3’-beta-C-Ethynyl inosine is a purine nucleoside analog. Purine nucleoside analogs have broad antitumor activity targeting indolent lymphoid malignancies. Anticancer mechanisms in this process rely on inhibition of DNA synthesis, induction of apoptosis, etc. 3’-beta-C-Ethynyl inosine is a click chemistry reagent, it contains an Alkyne group and can undergo copper-catalyzed azide-alkyne cycloaddition (CuAAc) with molecules containing Azide groups.
    3’-beta-C-Ethynyl inosine
  • HY-152489
    8-Chloro-2’-deoxy-2’-fluoro inosine
    8-Chloro-2’-deoxy-2’-fluoro inosine is a purine nucleoside analog. Purine nucleoside analogs have broad antitumor activity targeting indolent lymphoid malignancies. Anticancer mechanisms in this process rely on inhibition of DNA synthesis, induction of apoptosis, etc.
    8-Chloro-2’-deoxy-2’-fluoro inosine
  • HY-152730
    3’-Deoxy-3’-fluoroinosine 117517-20-1
    3’-Deoxy-3’-fluoroinosine is a purine nucleoside analogue. Purine nucleoside analogs have broad antitumor activity targeting indolent lymphoid malignancies. Anticancer mechanisms in this process rely on inhibition of DNA synthesis, induction of apoptosis, etc.
    3’-Deoxy-3’-fluoroinosine
  • HY-152655
    6-Ethoxy-9-beta-D-(2-C-methyl-ribofuranosyl)purine 848750-87-8
    6-Ethoxy-9-beta-D-(2-C-methyl-ribofuranosyl)purine is a purine nucleoside analog. Purine nucleoside analogs have broad antitumor activity targeting indolent lymphoid malignancies. Anticancer mechanisms in this process rely on inhibition of DNA synthesis, induction of apoptosis, etc.
    6-Ethoxy-9-beta-D-(2-C-methyl-ribofuranosyl)purine
  • HY-154467
    2′-Deoxy-6-thioinosine 2239-64-7
    2′-Deoxy-6-thioinosine is a purine nucleoside analog. Purine nucleoside analogs have broad antitumor activity targeting indolent lymphoid malignancies. Anticancer mechanisms in this process rely on inhibition of DNA synthesis, induction of apoptosis, etc.
    2′-Deoxy-6-thioinosine
  • HY-154201
    3’-Deoxy-O6-methyl inosine 945215-53-2
    3’-Deoxy-O6-methyl inosine is a purine nucleoside analog. Purine nucleoside analogs have broad antitumor activity targeting indolent lymphoid malignancies. Anticancer mechanisms in this process rely on inhibition of DNA synthesis, induction of apoptosis, etc.
    3’-Deoxy-O6-methyl inosine
  • HY-154204
    2'-Deoxy-2'-fluoroarabino inosine 98983-40-5
    2’-Deoxy-2’-fluoroarabino inosine is a purine nucleoside analog. Purine nucleoside analogs have broad antitumor activity targeting indolent lymphoid malignancies. Anticancer mechanisms in this process rely on inhibition of DNA synthesis, induction of apoptosis, etc.
    2'-Deoxy-2'-fluoroarabino inosine
  • HY-154392
    2-Chloro-2’-deoxy inosine 136834-39-4
    2-Chloro-2’-deoxy inosine is a purine nucleoside analog. Purine nucleoside analogs have broad antitumor activity targeting indolent lymphoid malignancies. Anticancer mechanisms in this process rely on inhibition of DNA synthesis, induction of apoptosis, etc.
    2-Chloro-2’-deoxy inosine
  • HY-154575
    2-[(3-Pyridyl) pyrrolidin-1-yl]-2’-deoxyinosine 882435-02-1
    2-[(3-Pyridyl) pyrrolidin-1-yl]-2’-deoxyinosine is a purine nucleoside analog. Purine nucleoside analogs have broad antitumor activity targeting indolent lymphoid malignancies. Anticancer mechanisms in this process rely on inhibition of DNA synthesis, induction of apoptosis, etc.
    2-[(3-Pyridyl) pyrrolidin-1-yl]-2’-deoxyinosine